Literature DB >> 6313966

cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus.

J Sorge, W Ricci, S H Hughes.   

Abstract

The v-src gene of Schmidt-Ruppin strain A of Rous sarcoma virus is flanked by a 115-nucleotide direct repeat. Mutants that lack either the upstream or downstream copy replicate normally. However, mutants that lack both copies do not replicate. Cloned viral DNA lacking both copies of the 115-nucleotide sequence is capable of directing the transcription of viral RNA posttransfection. This viral RNA is polyadenylated, spliced, exported from the nucleus, and translated into protein normally. However, virions isolated from the culture medium 48 h posttransfection lack viral RNA. When mutant DNA is contransfected with wild-type DNA, the virions produced 48 h later contain wild-type RNA but not mutant RNA, even though both RNAs are present in the cytoplasm. We propose that the 115-nucleotide element of Rous sarcoma-avian leukosis virus encodes a cis-acting sequence that is necessary for the proper incorporation of viral RNA into virions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313966      PMCID: PMC255399     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization.

Authors:  M Linial; E Medeiros; W S Hayward
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

2.  The leader sequence of the subgenomic mRNA's of Rous sarcoma virus is approximately 390 nucleotides.

Authors:  P B Hackett; R Swanstrom; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

3.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination.

Authors:  M P Goldfarb; R A Weinberg
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

5.  Intracellular restriction on the growth of induced subgroup E avian type C viruses in chicken cells.

Authors:  H L Robinson
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

6.  Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus.

Authors:  P R Shank; M Linial
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

7.  Molecular mechanism for the capture and excision of the transforming gene of avian sarcoma virus as suggested by analysis of recombinant clones.

Authors:  T Yamamoto; J S Tyagi; J B Fagan; G Jay; B deCrombrugghe; I Pastan
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

8.  Molecular cloning and characterization of avian sarcoma virus circular DNA molecules.

Authors:  W J DeLorbe; P A Luciw; H M Goodman; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

9.  Avian sarcoma virus Y73 genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus.

Authors:  N Kitamura; A Kitamura; K Toyoshima; Y Hirayama; M Yoshida
Journal:  Nature       Date:  1982-05-20       Impact factor: 49.962

10.  Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus.

Authors:  B Levinson; G Khoury; G Vande Woude; P Gruss
Journal:  Nature       Date:  1982-02-18       Impact factor: 49.962

View more
  67 in total

1.  Point mutations in the avian sarcoma/leukosis virus 3' untranslated region result in a packaging defect.

Authors:  J M Aschoff; D Foster; J M Coffin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.

Authors:  G P Harrison; A M Lever
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b.

Authors:  D J Anderson; P Lee; K L Levine; J S Sang; S A Shah; O O Yang; P R Shank; M L Linial
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Specificity of retroviral RNA packaging.

Authors:  R Aronoff; M Linial
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  A model system for nonhomologous recombination between retroviral and cellular RNA.

Authors:  A M Hajjar; M L Linial
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Transforming variants of the avian myc-containing retrovirus FH3 arise prior to phenotypic selection.

Authors:  A T Tikhonenko; M L Linial
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant.

Authors:  L Zhang; S B Simpson; C M Stoltzfus
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.